- H35.89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM H35.89 became effective on October 1, 2022.
- This is the American ICD-10-CM version of H35.89 – other international versions of ICD-10 H35.89 may differ.
ICD-10-CM H35.89 is grouped within Diagnostic Related Group(s):
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to H35.89:
- retina, retinal (postinfectional) > Atrophy, atrophic (of)
- retina > Chalcosis
- deposit > Cholesterol
- retina > deposit H35.89
- retina, retinal > Cyanosis R23.0
- retinal nerve bundle fibers > Defect, defective Q89.9
- cholesterol > Deposit
- retina > cholesterol H35.89
- specified NEC > retina, retinal H35.9
- specified type NEC > retina H35.9
- retina > Exudate
- retina > Hyperemia (acute) (passive) R68.89